Immunoactive products of human placenta (III): Characterization of an inhibitor affecting lymphocyte proliferation.
We have investigated the effects of supernatants from human placenta explant cultures on lymphokine dependent T cell proliferation using mainly the CTLL-2 reference murine cell line. A profound, dose dependent, inhibition of both IL-2 and IL-4-dependent cell proliferation was observed. In addition, supernatants from human placental cultures inhibited B cell proliferation, IL-5-driven proliferation of B13 cells, and IL-6-induced proliferation of 7TD.1. Conversely, the supernatants from human placental cultures enhance the growth of human embryonic fibroblasts. Characterization of the material by HPLC yielded a 68-70 kDa peak at pH 7.4, but the peak activity was at a smaller molecular weight (20-25 kDa) if pH 2.9 acetic acid, KC1 buffer was used. The same fractions were inhibitory for IL-2 and IL-4 driven proliferation of CTLL-2 cells. We conclude that the substances tested are acting as a general growth inhibitor for lymphocytes.
Menu
E
E
U 262 INSERM, Clinique Universitaire Baudelocque, Paris, France.
Jankovic
D L
DL
Theze
J
J
David
V
V
Chaouat
G
G
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002478:Cells, Cultured; D002851:Chromatography, High Pressure Liquid; D005260:Female; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007378:Interleukins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000276:immunology*; D008970:Molecular Weight; D010924:Placental Extracts / Q000032:analysis / Q000494:pharmacology*; D011247:Pregnancy; D013601:T-Lymphocytes / Q000276:immunology*
D007378:Interleukins; D010924:Placental Extracts